« Back to Record
Citation APA

Palmieri, C., Gojis, O., Januszewski, A., Lewanski, C., Asher, R., Lythgoe, D., de Azambuja, E., Beresford, M., Howell, S. S., Macpherson, I. R. J., Yan, K., Ades Moraes, F., Riddle, P., Ahmed, R., Owadally, W., Stanley, B., & Shah, D. (2016). Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with her2-positive breast cancer. Oncotarget, 7(11), 13209-13220. doi:10.18632/oncotarget.4801


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231570

Palmieri, C., Gojis, O., Januszewski, A., Lewanski, C., Asher, R., Lythgoe, D., de Azambuja, E., Beresford, M., Howell, S. S., Macpherson, I. R. J., Yan, K., Ades Moraes, F., Riddle, P., Ahmed, R., Owadally, W., Stanley, B., & Shah, D. (2016). Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with her2-positive breast cancer. Oncotarget, 7(11), 13209-13220. doi:10.18632/oncotarget.4801